Last reviewed: June 16, 2026

Last updated: June 16, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Start your GLP-1 program with PlexusDx

One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.

Start your intake →

The Standard Weekly Injection Schedule for Semaglutide

Semaglutide injections are administered once every seven days, typically on the same day each week. Most treatment protocols begin at 0.25 mg in week one, then follow a stepwise increase every 28 days—moving to 0.5 mg in week five, 1.0 mg in week nine, and potentially continuing to 1.7 mg or 2.4 mg depending on your clinical goals and response. This gradual titration reduces gastrointestinal side effects and allows your body to adapt to the medication's appetite-suppressing and metabolic effects.

Consistency matters more than perfection with timing. If you typically inject on Monday morning, injecting Tuesday or Wednesday of the same week poses no significant clinical problem; the key is maintaining the seven-day interval as closely as possible. PlexusDx provides clear injection guidance and reminder support to help patients stick to their weekly schedule without breaks or delays that could reduce treatment effectiveness.

Dose Escalation: Why Gradual Increases Work Better

Starting at a low dose and increasing every four weeks is not arbitrary—it reflects how your digestive system and metabolic pathways adapt to GLP-1 receptor activation. Jumping directly to high doses often triggers severe nausea, vomiting, and constipation that leads patients to discontinue treatment before experiencing benefits. Research shows that stepwise dose escalation improves medication tolerance and long-term adherence, resulting in better weight loss outcomes over six to twelve months.

Your dose may need to go up over time based on your weight loss plateau or clinical response, but your price stays flat with PlexusDx. Compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan regardless of whether you're taking 0.25 mg or 2.4 mg—removing the financial barrier to dose optimization. This flat pricing model encourages patients and providers to titrate to the most effective dose without worrying about escalating medication costs.

How Genetics Shape Your Ideal Semaglutide Response Timeline

The PlexusDx Precision Peptide Genetic Test analyzes GIPR — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Genetic insights also reveal whether your weight biology leans toward hunger-driven, metabolic-driven, or inflammation-driven patterns. A patient with specific FTO or MC4R variants may benefit from a slightly faster dose escalation schedule or earlier consideration of dual-peptide therapy like GLP-Squared. Testing for $298 allows PlexusDx providers to refine your injection protocol and potentially switch compounds if needed—personalizing your path to sustainable weight loss.

Maintaining Your Weekly Injection Habit: Tips for Consistency

Establishing a reliable weekly injection routine prevents missed doses and maintains steady medication levels in your bloodstream. Many patients pick the same day and time each week—for example, every Sunday evening—and link the injection to an existing habit like a weekly meal prep or Sunday night routine. Keeping your injection supplies visible in your refrigerator and setting phone reminders seven days apart helps prevent the accidental skip that could delay your weight loss progress.

PlexusDx provides detailed training on injection technique, needle size, and rotation sites during your initial consultation. Patients receiving compounded semaglutide from licensed 503A pharmacies receive clear written instructions on storage, expiration, and what to do if you miss a dose. If you miss an injection, the typical guidance is to take it as soon as you remember within a few days, then resume your regular weekly schedule—though your PlexusDx provider should clarify the best approach for your specific situation.

When to Adjust Your Semaglutide Schedule or Dose

Your semaglutide injection schedule may need adjustment if you experience severe side effects, reach a weight loss plateau lasting eight weeks or longer, or achieve your target weight. Dose reductions happen when nausea or other adverse effects persist despite waiting through the typical four-week adaptation window. Conversely, if you're losing weight steadily and tolerating your current dose well, your provider may recommend staying at that level rather than escalating further—especially if you're approaching your personal goal weight.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Can I take my semaglutide injection on a different day each week?

Yes, minor variations are acceptable—injecting a day or two earlier or later than usual doesn't harm treatment. The important factor is maintaining the weekly interval and returning to your regular schedule the following week. PlexusDx recommends picking a consistent day to build the habit, but missing your exact timing by 1–2 days is far less risky than skipping the injection entirely.

What does clinical evidence say about semaglutide weight loss over time?

Patients using semaglutide injections in phase 3 trials achieved average weight loss of 15–18% of body weight over 68 weeks, compared to 2–3% with placebo. Most weight loss occurs between weeks 12 and 52, with continued gradual improvement through the end of treatment. The stepwise four-week dose escalation protocol used in those trials mirrors the approach PlexusDx providers follow.

Why does PlexusDx charge a flat monthly price regardless of my semaglutide dose?

PlexusDx believes cost should never prevent you from reaching your optimal dose. Compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan and remain flat whether you're taking 0.25 mg or 2.4 mg weekly—removing the financial penalty for dose increases. This flat pricing model applies across all three commitment tiers and encourages providers to escalate doses based on clinical response rather than patient affordability.

Are there any safety concerns with the weekly semaglutide injection schedule?

The weekly injection protocol is established as safe and effective when following a gradual dose escalation. Serious adverse events are rare; the most common issues are mild-to-moderate nausea, constipation, and fatigue—which typically resolve within 1–2 weeks at each new dose level. Patients with a personal or family history of medullary thyroid cancer should avoid semaglutide; this is screened during your PlexusDx intake.

How does my genetic profile influence my semaglutide injection schedule?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves